News Archive

  • Are Biotechs a Contrarian Bet?

    Monday, February 13, 2017

    In Interactive Broker's Trader's Insight, TRADING CENTRAL's senior analyst Philippe Delabarre examines the performance of the healthcare sector.

  • A surprising recovery for health stocks

    Wednesday, February 8, 2017

    In the Globe and Mail Number Cruncher, Peter Ashton uses Recognia's Strategy Builder to find U.S. health-services stocks with strong profitability and reasonable valuations

  • Will 2017 be an Attractive Year for Emerging Markets?

    Thursday, January 26, 2017

    In the lastest IB Trader's Insight, TRADING CENTRAL analyst Philippe Delabarre comments on market expectations for 2017 in light of the Trump presidency, and the current recovery in industrial metals and oil.

  • Seeking U.S. tech stocks set to outperform

    Monday, January 23, 2017

    In the Globe and Mail Number Cruncher, Peter Ashton uses Recognia's Strategy Builder to find large-cap U.S. technology stocks with positive four-week price performance, reasonable valuations and low debt.

  • A new ‘gilded era’ for U.S. banks?

    Monday, January 9, 2017

    In the Globe and Mail Number Cruncher, Peter Ashton uses Recognia's Strategy Builder to find U.S. bank stocks offering reasonable valuations and efficient operations.

Pages

Subscribe to News Archive